Mirum Pharmaceuticals, Inc.
MIRM
$44.39
-$0.88-1.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.24% | 10.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.24% | 10.00% | |||
| Cost of Revenue | 1.04% | 9.49% | |||
| Gross Profit | 15.57% | 10.15% | |||
| SG&A Expenses | 1.54% | 12.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.53% | 19.96% | |||
| Operating Income | 37.32% | -90.96% | |||
| Income Before Tax | 43.99% | -75.45% | |||
| Income Tax Expenses | 278.65% | -265.99% | |||
| Earnings from Continuing Operations | 38.31% | -67.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.31% | -67.12% | |||
| EBIT | 37.32% | -90.96% | |||
| EBITDA | 49.74% | -174.04% | |||
| EPS Basic | 40.03% | -68.04% | |||
| Normalized Basic EPS | 45.55% | -76.39% | |||
| EPS Diluted | 40.03% | -68.04% | |||
| Normalized Diluted EPS | 45.55% | -76.39% | |||
| Average Basic Shares Outstanding | 2.88% | -0.54% | |||
| Average Diluted Shares Outstanding | 2.88% | -0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||